iRhythm Technologies Inc (IRTC)
73.99
+0.09
(+0.12%)
USD |
NASDAQ |
Nov 22, 16:00
73.88
-0.10
(-0.14%)
After-Hours: 20:00
iRhythm Technologies Enterprise Value: 2.440B for Nov. 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 2.440B |
| November 21, 2024 | 2.437B |
| November 20, 2024 | 2.432B |
| November 19, 2024 | 2.486B |
| November 18, 2024 | 2.529B |
| November 15, 2024 | 2.642B |
| November 14, 2024 | 2.735B |
| November 13, 2024 | 2.851B |
| November 12, 2024 | 2.853B |
| November 11, 2024 | 2.907B |
| November 08, 2024 | 2.830B |
| November 07, 2024 | 2.902B |
| November 06, 2024 | 2.925B |
| November 05, 2024 | 2.837B |
| November 04, 2024 | 2.673B |
| November 01, 2024 | 2.472B |
| October 31, 2024 | 2.391B |
| October 30, 2024 | 2.495B |
| October 29, 2024 | 2.534B |
| October 28, 2024 | 2.512B |
| October 25, 2024 | 2.492B |
| October 24, 2024 | 2.569B |
| October 23, 2024 | 2.451B |
| October 22, 2024 | 2.489B |
| October 21, 2024 | 2.067B |
| Date | Value |
|---|---|
| October 18, 2024 | 2.085B |
| October 17, 2024 | 2.079B |
| October 16, 2024 | 2.056B |
| October 15, 2024 | 2.005B |
| October 14, 2024 | 1.936B |
| October 11, 2024 | 1.909B |
| October 10, 2024 | 1.919B |
| October 09, 2024 | 1.959B |
| October 08, 2024 | 2.007B |
| October 07, 2024 | 2.012B |
| October 04, 2024 | 2.086B |
| October 03, 2024 | 2.197B |
| October 02, 2024 | 2.346B |
| October 01, 2024 | 2.363B |
| September 30, 2024 | 2.447B |
| September 27, 2024 | 2.360B |
| September 26, 2024 | 2.321B |
| September 25, 2024 | 2.354B |
| September 24, 2024 | 2.279B |
| September 23, 2024 | 2.272B |
| September 20, 2024 | 2.270B |
| September 19, 2024 | 2.366B |
| September 18, 2024 | 2.302B |
| September 17, 2024 | 2.317B |
| September 16, 2024 | 2.386B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.004B
Minimum
Aug 19 2021
7.488B
Maximum
Jan 20 2021
3.251B
Average
3.114B
Median
Aug 17 2023
Enterprise Value Benchmarks
| Abbott Laboratories | 211.67B |
| Boston Scientific Corp | 141.27B |
| Perspective Therapeutics Inc | -31.63M |
| Xtant Medical Holdings Inc | 83.10M |
| Catheter Precision Inc | 3.859M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -46.18M |
| Revenue (Quarterly) | 147.54M |
| Total Expenses (Quarterly) | 197.20M |
| EPS Diluted (Quarterly) | -1.48 |
| Gross Profit Margin (Quarterly) | 68.78% |
| Profit Margin (Quarterly) | -31.30% |
| Earnings Yield | -6.57% |
| Normalized Earnings Yield | -5.900 |